Hope in sight TM

Our research is bringing hope to people affected by vision loss and blindness

Donate Now

Become a Luminary with monthly giving

By making a commitment and pledging a monthly donation of your choice, you too can make a significant difference to our world-leading research and clinical trials, and most importantly, for people living with eye disease.

Annual Review

This year CERA’s Annual Review highlights some of the incredible people supporting us on our mission to develop better treatments and faster diagnoses for eye disease.


Our free guide gives you an essential introduction to age-related macular degeneration (AMD), and a snapshot of the latest research conducted at CERA.


In this video, learn about CERA’s research into gene therapies that could halt or even reverse vision loss in patients with conditions such as inherited retinal diseases and glaucoma.

Donate to CERA

With your support, there’s hope in sight.

Your gift will contribute to our world-leading vision research, making a real difference to people affected by vision loss and blindness.

Donate now

Take part in research

We conduct world-leading clinical trials for a range of eye conditions.

Learn more about taking part in clinical trials for conditions like age-related macular degeneration, glaucoma, diabetic retinopathy and more.

Learn more

Latest News


19 August 2022

The discovery of molecular signatures of age-related macular degeneration has the potential to improve both the diagnosis and treatment of this progressive eye disease.


21 July 2022

A new start-up company aiming to develop a gene therapy to ‘switch on sight’ by restoring the retina’s light-sensing cells has won vital funding to accelerate its research.


28 July 2022

Research aimed at improving the screening process for diabetic eye disease and better understanding communication between the retina and brain has received new support.


28 July 2022

A Lions Fellowship awarded to Dr Heather Machin is set to have a significant impact on improving eye donations in both Melbourne and further afield.

Eye-news emails are sent to subscribers once a month

Newsletter Subscribe
Receive Appeals